Shares of psychedelic drug developers rose in premarket trading on Monday after President Donald Trump signed an executive order directing health regulators to speed up reviews of psychedelic drugs and boosted federal research funding.Shares of Atai Life Sciences jumped…[#item_full_content]
US Plans G20 Talks on War’s Food, Fertilizer Impact
The U.S. will host further talks in coming weeks for the Group of 20 major economies on the impact of the war in the Middle